Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Completed 3Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Barrett Esophagus 2Gastroesophageal Reflux 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Endoscopes × Clear all
NCT04301986 2023-05-08

Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus

University of North Carolina, Chapel Hill

Phase NA Completed
24 enrolled 9 charts
Gastrointestinal

Barrett Esophagus, Gastroesophageal Reflux

NCT02729948 2019-01-23

Tethered Capsule Endoscope in Screening Patients With Barrett Esophagus

University of Washington

Phase NA Completed
1 enrolled
Gastrointestinal

Barrett Esophagus

NCT01172860 2017-11-09

CCEE EndoVe

Mercy University Hospital, Cork, Ireland

Phase 1 Completed
10 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡